| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
232,133 |
191,222 |
$48.42M |
| 00003 |
Internal/system code - not a standard HCPCS code |
11,443 |
9,320 |
$3.11M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
158,688 |
106,814 |
$145K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
48,110 |
32,579 |
$56K |
| 90834 |
Psychotherapy, 45 minutes with patient |
4,055 |
2,900 |
$23K |
| D1120 |
Prophylaxis - child |
1,654 |
1,253 |
$19K |
| D1206 |
Topical application of fluoride varnish |
4,186 |
3,392 |
$18K |
| D0120 |
Periodic oral evaluation - established patient |
1,726 |
1,250 |
$14K |
| J3490 |
Unclassified drugs |
127 |
113 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,195 |
2,580 |
$12K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,405 |
20,718 |
$11K |
| 90791 |
Psychiatric diagnostic evaluation |
1,235 |
1,123 |
$10K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
1,518 |
1,299 |
$7K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
10,656 |
6,878 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
9,442 |
6,320 |
$6K |
| D0220 |
Intraoral - periapical first radiographic image |
2,908 |
2,203 |
$6K |
| D0230 |
Intraoral - periapical each additional radiographic image |
1,904 |
1,463 |
$5K |
| 90670 |
|
4,723 |
3,380 |
$5K |
| 0011A |
|
104 |
101 |
$5K |
| 92552 |
|
21,431 |
14,242 |
$5K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,953 |
1,450 |
$5K |
| 90734 |
|
1,058 |
844 |
$5K |
| D0274 |
Bitewings - four radiographic images |
1,045 |
798 |
$5K |
| D9430 |
|
1,725 |
1,284 |
$4K |
| 0012A |
|
59 |
59 |
$4K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
6,904 |
4,653 |
$4K |
| D0145 |
Oral evaluation for a patient under three years of age |
366 |
294 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
4,013 |
3,040 |
$3K |
| 90710 |
|
650 |
464 |
$3K |
| D0210 |
Intraoral - complete series of radiographic images |
821 |
705 |
$3K |
| 90686 |
|
14,812 |
10,880 |
$2K |
| 99000 |
|
69,075 |
54,006 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
49,688 |
39,919 |
$2K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
437 |
385 |
$2K |
| 81025 |
|
10,412 |
8,455 |
$2K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
329 |
329 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
547 |
405 |
$1K |
| 90651 |
|
2,661 |
1,950 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,475 |
4,498 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
3,591 |
2,742 |
$1K |
| 59425 |
|
7,196 |
4,993 |
$1K |
| 90621 |
|
360 |
258 |
$1K |
| 90716 |
|
414 |
299 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,724 |
1,603 |
$883.25 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
2,343 |
1,469 |
$815.48 |
| 90723 |
|
4,027 |
2,840 |
$726.42 |
| 97803 |
|
2,982 |
2,069 |
$697.95 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
202 |
140 |
$682.05 |
| 96150 |
|
1,048 |
892 |
$660.45 |
| 0001A |
|
13 |
13 |
$659.88 |
| 90715 |
|
1,610 |
1,300 |
$641.55 |
| 90696 |
|
337 |
253 |
$639.23 |
| 81002 |
|
13,905 |
8,745 |
$541.29 |
| 85018 |
|
35,244 |
25,067 |
$393.60 |
| 96151 |
|
97 |
84 |
$379.94 |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
347 |
308 |
$350.70 |
| 90647 |
|
4,440 |
3,146 |
$345.94 |
| 93000 |
|
1,458 |
1,076 |
$340.92 |
| 96127 |
|
9,983 |
6,694 |
$295.12 |
| 90707 |
|
348 |
253 |
$238.44 |
| 94760 |
|
7,286 |
4,305 |
$196.32 |
| 97802 |
|
1,111 |
810 |
$180.30 |
| 90633 |
|
2,111 |
1,459 |
$179.59 |
| 81003 |
|
8,368 |
6,391 |
$166.47 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,780 |
1,593 |
$164.70 |
| D1110 |
Prophylaxis - adult |
32 |
25 |
$161.50 |
| D9999 |
Unspecified adjunctive procedure, by report |
49 |
39 |
$151.20 |
| D4341 |
|
564 |
417 |
$140.00 |
| 99381 |
|
337 |
275 |
$134.64 |
| 90700 |
|
420 |
289 |
$120.88 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
317 |
315 |
$101.79 |
| D0270 |
|
104 |
77 |
$98.50 |
| 82948 |
|
1,638 |
1,381 |
$77.72 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12,931 |
10,578 |
$48.44 |
| D0272 |
Bitewings - two radiographic images |
14 |
12 |
$44.00 |
| 90688 |
|
2,414 |
1,795 |
$36.00 |
| 83037 |
|
5,939 |
4,421 |
$30.61 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
392 |
291 |
$18.56 |
| 1030F |
|
544 |
542 |
$11.25 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
252 |
191 |
$6.92 |
| D0350 |
|
90 |
71 |
$6.60 |
| 3074F |
|
11,176 |
10,092 |
$5.00 |
| 84702 |
|
134 |
126 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15,378 |
15,310 |
$0.00 |
| 82947 |
|
4,390 |
4,099 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,217 |
6,148 |
$0.00 |
| 99173 |
|
35,178 |
24,913 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
820 |
817 |
$0.00 |
| 90681 |
|
753 |
705 |
$0.00 |
| 80061 |
Lipid panel |
5,152 |
5,144 |
$0.00 |
| 99177 |
|
323 |
248 |
$0.00 |
| H1003 |
Prenatal care, at-risk enhanced service; education |
2,437 |
2,230 |
$0.00 |
| 3078F |
|
11,400 |
10,338 |
$0.00 |
| 80074 |
|
677 |
674 |
$0.00 |
| 90461 |
|
6,809 |
6,795 |
$0.00 |
| V2020 |
Frames, purchases |
82 |
82 |
$0.00 |
| Z6400 |
|
2,536 |
2,513 |
$0.00 |
| 1160F |
|
3,857 |
3,696 |
$0.00 |
| 86703 |
|
295 |
295 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
369 |
366 |
$0.00 |
| 99401 |
|
947 |
913 |
$0.00 |
| 3077F |
|
1,648 |
1,571 |
$0.00 |
| Z6300 |
|
500 |
500 |
$0.00 |
| 92015 |
Determination of refractive state |
1,819 |
1,813 |
$0.00 |
| 84439 |
|
498 |
497 |
$0.00 |
| 87660 |
|
557 |
553 |
$0.00 |
| 87210 |
|
590 |
590 |
$0.00 |
| 3725F |
|
769 |
769 |
$0.00 |
| 2028F |
|
115 |
115 |
$0.00 |
| 83540 |
|
110 |
110 |
$0.00 |
| 1159F |
|
248 |
248 |
$0.00 |
| Z6200 |
|
500 |
500 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
1,977 |
1,355 |
$0.00 |
| 92201 |
|
14 |
14 |
$0.00 |
| 3015F |
|
662 |
654 |
$0.00 |
| D9996 |
|
152 |
121 |
$0.00 |
| Z6304 |
|
275 |
275 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
75 |
74 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
26 |
26 |
$0.00 |
| 3046F |
|
57 |
54 |
$0.00 |
| 86787 |
|
175 |
175 |
$0.00 |
| 86765 |
|
55 |
55 |
$0.00 |
| A4614 |
Peak expiratory flow rate meter, hand held |
370 |
333 |
$0.00 |
| 85014 |
|
27 |
26 |
$0.00 |
| 99080 |
|
325 |
305 |
$0.00 |
| Z6202 |
|
113 |
112 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
52 |
52 |
$0.00 |
| 3051F |
|
32 |
32 |
$0.00 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
152 |
152 |
$0.00 |
| 83655 |
|
101 |
101 |
$0.00 |
| Z6308 |
|
30 |
29 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
29 |
29 |
$0.00 |
| 90746 |
|
86 |
73 |
$0.00 |
| Z6208 |
|
29 |
29 |
$0.00 |
| 0521F |
|
490 |
466 |
$0.00 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
154 |
148 |
$0.00 |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
39 |
39 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
27 |
27 |
$0.00 |
| 94664 |
|
21 |
12 |
$0.00 |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
67 |
65 |
$0.00 |
| 81243 |
|
30 |
30 |
$0.00 |
| 92341 |
|
17 |
17 |
$0.00 |
| Z6414 |
|
29 |
29 |
$0.00 |
| 3050F |
|
12 |
12 |
$0.00 |
| 87254 |
|
53 |
52 |
$0.00 |
| 90713 |
|
34 |
24 |
$0.00 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
51 |
50 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
22 |
13 |
$0.00 |
| 90662 |
|
37 |
25 |
$0.00 |
| 85041 |
|
29 |
28 |
$0.00 |
| 86735 |
|
53 |
53 |
$0.00 |
| 80076 |
|
35 |
35 |
$0.00 |
| 86592 |
|
3,134 |
3,124 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,099 |
2,094 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,041 |
5,975 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,483 |
4,470 |
$0.00 |
| 87480 |
|
581 |
577 |
$0.00 |
| Z1034 |
|
14,100 |
10,308 |
$0.00 |
| 88142 |
|
185 |
184 |
$0.00 |
| 3079F |
|
3,199 |
3,092 |
$0.00 |
| 90656 |
|
1,503 |
953 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
6,344 |
6,319 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,609 |
6,576 |
$0.00 |
| Z6410 |
|
1,560 |
1,459 |
$0.00 |
| 3008F |
|
1,521 |
1,452 |
$0.00 |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
121 |
108 |
$0.00 |
| 86706 |
|
781 |
781 |
$0.00 |
| D7140 |
Extraction, erupted tooth or exposed root |
183 |
165 |
$0.00 |
| D0603 |
|
5,143 |
4,199 |
$0.00 |
| Z6402 |
|
500 |
500 |
$0.00 |
| 96156 |
|
4,575 |
3,376 |
$0.00 |
| 86803 |
|
1,250 |
1,248 |
$0.00 |
| 80055 |
|
344 |
344 |
$0.00 |
| 87510 |
|
548 |
545 |
$0.00 |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
2,703 |
1,959 |
$0.00 |
| 3075F |
|
2,377 |
2,323 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,425 |
1,384 |
$0.00 |
| 99383 |
|
70 |
49 |
$0.00 |
| Z1032 |
|
1,125 |
1,123 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,371 |
2,366 |
$0.00 |
| 3044F |
|
715 |
699 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,251 |
4,238 |
$0.00 |
| Z6406 |
|
347 |
346 |
$0.00 |
| 81001 |
|
2,908 |
2,864 |
$0.00 |
| 92002 |
|
1,270 |
1,269 |
$0.00 |
| 90677 |
|
241 |
241 |
$0.00 |
| 3014F |
|
422 |
420 |
$0.00 |
| 87340 |
|
951 |
950 |
$0.00 |
| D1330 |
|
4,092 |
3,280 |
$0.00 |
| 82746 |
|
228 |
228 |
$0.00 |
| 90619 |
|
757 |
536 |
$0.00 |
| 86762 |
|
92 |
92 |
$0.00 |
| Z6204 |
|
709 |
692 |
$0.00 |
| D1351 |
Sealant - per tooth |
26 |
26 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
131 |
130 |
$0.00 |
| 86704 |
|
623 |
623 |
$0.00 |
| S9451 |
Exercise classes, non-physician provider, per session |
143 |
143 |
$0.00 |
| 82105 |
|
126 |
120 |
$0.00 |
| 1126F |
|
196 |
196 |
$0.00 |
| 3080F |
|
593 |
568 |
$0.00 |
| 83550 |
|
96 |
96 |
$0.00 |
| Z1038 |
|
98 |
98 |
$0.00 |
| 82607 |
|
204 |
204 |
$0.00 |
| 82728 |
|
81 |
81 |
$0.00 |
| 90744 |
|
52 |
52 |
$0.00 |
| 99384 |
|
36 |
25 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
181 |
181 |
$0.00 |
| 82043 |
|
102 |
101 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
518 |
518 |
$0.00 |
| 90480 |
|
32 |
26 |
$0.00 |
| 86580 |
|
127 |
126 |
$0.00 |
| 87081 |
|
27 |
26 |
$0.00 |
| 99462 |
|
17 |
16 |
$0.00 |
| 99460 |
|
142 |
138 |
$0.00 |
| 59430 |
|
111 |
111 |
$0.00 |
| 87088 |
|
13 |
12 |
$0.00 |
| 82962 |
|
58 |
57 |
$0.00 |
| 3052F |
|
16 |
16 |
$0.00 |
| 83021 |
|
41 |
40 |
$0.00 |
| S9452 |
Nutrition classes, non-physician provider, per session |
13 |
13 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
77 |
56 |
$0.00 |
| 99385 |
|
24 |
24 |
$0.00 |
| D0140 |
Limited oral evaluation - problem focused |
14 |
12 |
$0.00 |
| 82950 |
|
13 |
13 |
$0.00 |
| 94010 |
|
27 |
15 |
$0.00 |
| D5899 |
|
18 |
12 |
$0.00 |
| 3017F |
|
16 |
16 |
$0.00 |
| 85027 |
|
12 |
12 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
45 |
44 |
$0.00 |
| 86850 |
|
12 |
12 |
$0.00 |